Pharmaceutical
| Thu 09 Apr 2026
Alexandria, April 9 -- Merck Sharp & Dohme has been granted a patent for PRMT5 Inhibitors. This invention was developed by Machacek Michelle, Altman Michael D, Huang Chunghui, Reutershan Michael H, Sloman David L, Siliphaivanh Phieng, Schneider Sebastian E, Yeung Charles S, Witter David J, Gibeau Craig R and Ye Yingchun.
The ..